---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-002389"
form_type: "8-K"
ticker: "MGRX"
cik: "0001938046"
company_name: "MANGOCEUTICALS, INC."
filed_at: "2025-01-15T23:59:59+00:00"
generated_at: "2026-05-28T01:26:06.202558+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Mangoceuticals subsidiary creates Series A Preferred Stock granting CEO 51% voting control

## Summary
- Series A Preferred Stock of M&P subsidiary gives holders 51% of total vote on all shareholder matters.
- 100 shares designated; expected to be issued to CEO Jacob Cohen under his employment agreement.
- M&P cannot amend charter or issue more shares without 66-2/3% approval of Series A holders.
- Designation filed Jan 9, 2025, effective same date; filed with Texas SOS on Jan 15.

## SEC filing metadata
- accession: 0001493152-25-002389
- form_type: 8-K
- ticker: MGRX
- cik: 0001938046
- company_name: MANGOCEUTICALS, INC.
- filed_at: 2025-01-15T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1938046/000149315225002389/0001493152-25-002389-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1938046/000149315225002389/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-002389
- JSON: https://secwatch.observer/filing/0001493152-25-002389.json
- Plain text: https://secwatch.observer/filing/0001493152-25-002389.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.